期刊
TRENDS IN IMMUNOLOGY
卷 32, 期 8, 页码 373-379出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.it.2011.05.004
关键词
-
类别
资金
- NHLBI NIH HHS [R01 HL093262-01A1, R01 HL093262] Funding Source: Medline
- NIAID NIH HHS [R01 AI083713-01, R01 AI083713] Funding Source: Medline
A strong link between inflammation and metabolism is becoming increasingly evident. A number of recent landmark studies have implicated the activation of the NLRP3 inflammasome, an interleukin-10 family cytokine-activating protein complex, in a variety of metabolic diseases including obesity, atherosclerosis and type 2 diabetes. Here, we review these new developments and discuss their implications for a better understanding of inflammation in metabolic disease, and the prospects of targeting the NLRP3 inflammasome for therapeutic intervention.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据